EXO EXOR N.V.

Exor N.V.: Periodic Report on the Buyback Program

Exor N.V.: Periodic Report on the Buyback Program

EXOR N.V. (AMS: EXO) (“Exor” or the “Company”) announces that, under the second tranche of the share buyback program of up to €250 million announced on 29 July 2022 (the “second tranche”), the Company has completed the following transactions on Euronext Amsterdam:

Trading DateNumber of ordinary shares purchasedAverage price per share excluding fees (€)Total consideration excluding fees (€)
19 December 202234,45569.89472,408,221.89
20 December 202232,08768.80432,207,723.57
21 December 202236,91569.26512,556,921.17
22 December 202222,33168.38861,527,185.83
23 December 202228,77268.41921,968,557.22
TOTAL 154,560   10,668,609.68

After these purchases, the total invested amount under the second tranche is approximately €150.5 million for a total amount of 2,237,534 ordinary shares purchased.

As of 23 December 2022, the Company held in total 13,025,632 ordinary shares in treasury (5.40% of total ordinary issued share capital).

A comprehensive overview of the transactions carried out under the share buyback program, as well as the details of the above transactions, are available on Exor’s corporate website under the .

Attachment



EN
27/12/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on EXOR N.V.

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

ABN Amro: Miss but strong capital, good set of results / Ahold Delhaize: Strong 4Q25 but no major surprise on FY26 adj. EPS guidance / Alfen: No recovery yet and another transitional year / BAM Group: Preview: 2026 outlook the key item / Econocom: Better REBITA, net debt, but EBIT below, much lower net profit, dividend halved, 2026-28 guidance postponed to “medium term” / Exor: Ferrari 4Q25 and 2026 guidance beat / Gecina: Results and guidance in line, DPS set to grow over 2026-30 / Heineken: No...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ahold Delhaize: Serbia regulation to be litigated at international level. CM.com: Preview FY25. dsm-firmenich: At last! Exor: Stellantis shares fall sharply on €22bn turnaround plan, writeoff. Euronext: 2026 starting strong. Proximus: €275m impairment at Proximus Global

 PRESS RELEASE

Exor Press Release - 2026 Corporate Calendar

Exor Press Release - 2026 Corporate Calendar Amsterdam, 30 January 2026 EXOR PUBLISHES ITS 2026 CORPORATE CALENDAR Exor N.V. announced today the following corporate calendar for 2026: 23 March 2026: Publication of the financial statements for the full year 202524 March 2026: Investor & Analyst Call20 May 2026: Annual General Meeting of Shareholders22 September 2026: Publication of the interim financial statements for the half year 2026 The 2026 corporate calendar will be available on Exor’s website under the section. Any changes will be disclosed to the market on a timely basis. ...

 PRESS RELEASE

Exor-Ferrari Family Press Release - Shareholders' Agreement

Exor-Ferrari Family Press Release - Shareholders' Agreement Amsterdam, 3 January 2026 EXOR AND THE FERRARI FAMILY EXTEND SHAREHOLDERS’ AGREEMENT ON FERRARI Exor N.V., on the one hand, and Piero Ferrari and Trust Piero Ferrari, on the other hand, have agreed to renew the shareholders’ agreement relating to Ferrari N.V., confirming their respective alignment and commitment to Ferrari.         The new agreement enters into force upon expiration of the current shareholders’ agreement and will have a three-year term until 4 January 2029, with an automatic renewal for a further three-year perio...

Hilde Van Boxstael ... (+7)
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Livio Luyten
  • Michiel Declercq
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi

ResearchPool Subscriptions

Get the most out of your insights

Get in touch